| Nome do produto |
Cilastatin sodium |
| Sinônimos |
Primaxin; Cilastatin natrium; L 642957; MK 0791; MK 791; Sodium (Z)-7-(((R)-2-amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoate; UNII-5428WXZ74M; 2-Heptenoic acid, 7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)-, monosodium salt, (R-(R*,S*-(Z)))-; Sodium hydrogen (R-(R*,S*-(Z)))-7-((2-amino-2-carboxylatoethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)hept-2-enoate; sodium (2Z)-7-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoate; sodium (2Z)-7-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoate |
| Fórmula molecular |
C16H25N2NaO5S |
| Peso Molecular |
380.4349 |
| InChI |
InChI=1/C16H26N2O5S.Na/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21;/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23);/q;+1/p-1/b12-6-;/t10-,11+;/m1./s1 |
| CAS Registry Number |
81129-83-1 |
| EINECS |
279-694-4 |
| Estrutura Molecular |
|
| Ponto de ebulição |
655.5°C at 760 mmHg |
| O ponto de inflamação |
350.2°C |
| Símbolos de perigo |
|
| Códigos de risco |
|
| Descrição da Segurança |
|
|
